Nutriband (NTRB) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Nutriband (NTRB) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.39 of bullish evidence against -0.49 bearish.

Nutriband last closed at $7.47, +2.61% on the session.

Against the IVW growth benchmark the position is +1.69% over the forecast window.

The read is built from 13 underlying insights — 3 bullish and 10 bearish.

Agreement across those insights is 77%.

16 graded predictions for NTRB so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Nutriband in the 10th percentile on return on equity, where 100 is best.

Nutriband is classified under Health Care / Pharmaceuticals, with a market capitalisation of $88.50M.

StockMap tracks Nutriband as the 90th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Nutriband ranks 71st of 128 in the group, against a group median of -0.24.